Huntington's disease (HD) causes preferential loss of a subset of neurons in the brain although the huntingtin protein is expressed broadly in various neural cell types, including astrocytes. Glutamate-mediated excitotoxicity is thought to cause selective neuronal injury, and brain astrocytes have a central role in regulating extracellular glutamate. To determine whether full-length mutant huntingtin expression causes a cell-autonomous phenotype and perturbs astrocyte gliotransmitter release, we studied cultured cortical astrocytes from BACHD mice. Here, we report augmented glutamate release through Ca 2+ -dependent exocytosis from BACHD astrocytes. Although such release is usually dependent on cytosolic Ca 2+ levels, surprisingly, we found that BACHD astrocytes displayed Ca 2+ dynamics comparable to those in wild type astrocytes. These results point to a possible involvement of other factors in regulating Ca
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-dependent/vesicular release of glutamate from astrocytes. We found a biochemical footprint that would lead to increased availability of cytosolic glutamate in BACHD astrocytes: i) augmented de novo glutamate synthesis due to an increase in the level of the astrocyte specific mitochondrial enzyme pyruvate carboxylase; and ii) unaltered conversion of glutamate to glutamine, as there were no changes in the expression level of the astrocyte specific enzyme glutamine synthetase. This work identifies a new mechanism in astrocytes that could lead to increased levels of extracellular glutamate in HD and thus may contribute to excitotoxicity in this devastating disease.
Introduction
Huntington's disease (HD) is an autosomal dominant, progressive and fatal neurodegenerative disorder caused by a CAG repeat expansion in the gene encoding the widely expressed protein huntingtin (htt) (Sharp et al., 1995; Singhrao et al., 1998; The Huntington's Disease Collaborative Research Group, 1993) . Neurodegeneration is most prominent in striatal medium spiny neurons (MSNs) and to a lesser extent in cortical pyramidal neurons (Hedreen et al., 1991; Vonsattel et al., 1985) . Expression of mutant htt (mhtt) is necessary in multiple neural cell types to recapitulate key features of HD. When expression is limited to only pyramidal neurons in the cortex or MSNs in the striatum in mice, no significant neurodegenerative changes occur (Gu et al., 2005 (Gu et al., , 2007 . Thus, various cell types are likely key for the development of HD phenotypes.
One major hypothesis in HD is excitotoxicity caused principally by excessive activation of the N-methyl-D-aspartate receptors (NMDARs) (Fan and Raymond, 2007) . There is extensive glutamatergic input to the striatum and cortex, with high densities of NMDARs on MSNs (Albin et al., 1992; Landwehrmeyer et al., 1995) . Intrastriatal injections of NMDAR agonists in primates and mice lead to degeneration and morphological changes in MSNs resembling HD patient pathology (Beal et al., 1986) .
The htt protein is present in astrocytes (Singhrao et al., 1998) and evidence exists for altered astrocytic function in HD (Faideau et al., 2010; Vonsattel and DiFiglia, 1998) . In the R6/2 model, there is defective astrocytic glutamate uptake (Behrens et al., 2002; Lievens et al., 2001) , and an associated increase in extracellular glutamate in the striatum (Arzberger et al., 1997; Hassel et al., 2008) . Astrocytes from R6/2 mice increase neuronal vulnerability to toxicity, while wild type (WT) astrocytes protect mhtt expressing neurons against toxicity (Shin et al., 2005) . 
